Home> Products 
EIDD-2801isanoralbioavailableprodrugoftheribonucleosideanalogueEIDD-1931.EIDD-2801hasbroad-spectrumantiviralactivityagainstinfluenzavirChemicalbookusandavarietyofcoronaviruses(suchasSARS-CoV-2,MERS-CoV,SARS-CoV).EIDD-2801hasthepotentialtotreatCOVID-19andseasonalandpandemicinfluenza.
Product Name: Molnupiravir
CAS NO: 2349386-89-4
Synonyms:EIDD-2801;
((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;
Pharmacological action:EIDD-2801isacompoundsimilartoRemdesivir.
Bothdrugsworkbymimickingribonucleotides(themaincomponentofRNAmolecules).
Intheprocessofvirusreplication,
Quality Assurance:
COA will be provided before making payment.
Product standards strictly complies to COA.
If any quality problem verified , 100% replace product or return payment.
If still feel worried, sample can be provided.
Specification:
|
Items |
Specifications |
Results |
|
Appearance |
White to off-white powder |
white powder |
|
Identification |
HPLC:The retention time of main peak of test product is consistent with that of standard |
Complies |
|
Solubility |
Freely soluble in water |
Complies |
|
Water content |
NMT 0.5% |
0.17% |
|
Related Substance |
CD NMT 0.1% |
N.D. |
|
MPLW01 NMT 0.1% |
N.D. |
|
|
MPLW02 NMT 0.1% |
N.D. |
|
|
MPLW03 NMT 0.1% |
0.076% |
|
|
Any unspecific individual impurity NMT 0.2% |
0.036% |
|
|
Total impurity NMT1.5% |
0.18% |
|
|
Purity (HPLC) |
NLT 98.5% |
99.84% |
|
Residue on ignition |
NMT 0.2% |
0.025% |
|
Heavy metals |
NMT 10ppm |
Complies |
|
Microbial Limit |
Total aerobic bacteria NMT 100cfu/g |
＜10cfu/g |
|
Total number of moulds and yeasts NMT 100cfu/g |
＜10cfu/g |
|
|
Bacterial Endotoxin |
NMT 0.5EU/mg |
Complies |
|
Assay（HPLC） |
98.0%~102.0% |
99.3% |
|
Conclusion |
The product conforms to the above specifications |
|
|
Storage |
Sealed preservation at room temperature |
|
← HYALURONIC ACID | Chemical High Purity 99.99% RITONAVIR Cas 155213-67-5 RITONAVIR POWDER →
